Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net increase (decrease) in net assets resulting from operations $ 625,544 $ 507,396
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net change in unrealized (appreciation) depreciation on investments (132,042) (163,057)
Net realized (gain) loss on investments 16,022 16,749
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts 32,510 (5,835)
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies 9,696 (25,907)
Net accretion of discount and amortization of premium, net (65,436) (28,646)
Amortization of deferred financing costs 6,057 4,458
Amortization of original issue discount and debt issuance costs 6,469 1,362
Amortization of offering costs 1,424 1,215
Payment-in-kind interest capitalized (50,350) (21,038)
Payment-in-kind dividends capitalized (2,789) 0
Non-cash other income capitalized 0 (533)
Purchases of investments (5,238,438) (2,326,252)
Proceeds from sale of investments and principal repayments 1,795,781 545,433
Changes in operating assets and liabilities:    
Interest receivable from non-controlled/non-affiliated investments (45,237) (22,651)
Dividend receivable from non-controlled/non-affiliated investments 36 (87)
Receivable for investments (263,885) (75,781)
Other assets 349 (16,641)
Payable for investments purchased (40,841) 5,985
Interest payable 16,918 23,487
Due to affiliates (1,084) 6,439
Management fees payable 2,539 4,698
Income based incentive fees payable 8,910 18,660
Capital gains incentive fees payable 9,955 2,217
Distribution and/or shareholder servicing fees payable 648 259
Accrued expenses and other liabilities 45,187 92
Net cash provided by (used in) operating activities (3,262,057) (1,547,978)
Cash flows from financing activities:    
Borrowings on debt 5,240,200 4,259,688
Repayments of debt (3,926,833) (3,198,709)
Deferred financing costs paid (8,889) (14,412)
Debt issuance costs paid (49,291) (7,066)
Deferred offering costs paid (1,848) (2,062)
Proceeds from issuance of Common Shares 2,530,107 960,960
Common Shares repurchased, net of early repurchase deduction (179,260) (134,183)
Distributions paid in cash (302,901) (184,591)
Net cash provided by (used in) financing activities 3,301,285 1,679,625
Net increase (decrease) in cash and cash equivalents 39,228 131,647
Cash and cash equivalents, beginning of period 188,775 74,241
Cash and cash equivalents, end of period 228,003 205,888
Supplemental information and non-cash activities:    
Interest paid during the period 251,591 148,921
Taxes paid during the period 1,522 819
Distribution payable 64,675 38,188
Share repurchases accrued but not paid 45,160 34,830
Reinvestment of distributions during the period 207,648 126,554
Non-cash purchases of investments 3,045 37,396
Non-cash sales of investments $ (3,045) $ (37,396)